EE488 How Is Real-World Data Used in Health Technology Assessments to Inform Reimbursement Decisions for Multiple Sclerosis Drugs? A European Perspective

Abstract

Authors

A Cristea M Persson

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×